欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/2215/003
药品名称
Dabigatran etexilate Liconsa
活性成分
Dabigatranetexilatmesilat mesilate 150.0 mg
剂型
Capsule, hard
上市许可持有人
Laboratorios Liconsa S.A. Spain
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Luxembourg (LU)
Spain (ES)
Portugal (PT)
Finland (FI)
Belgium (BE)
Dabigatran etexilate Liconsa 150 mg harde capsules
许可日期
2024/06/26
最近更新日期
2024/08/08
药物ATC编码
B01AE07 dabigatran etexilate
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
Final PL
Date of last change:2024/09/06
Final SPC
|
Final SPC
Date of last change:2024/09/06
PubAR
|
PubAR _ Public assessment report
PubAR Summary
|
PubAR Summary _ Public assessment report summary
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase